mizoribine has been researched along with Diffuse Parenchymal Lung Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jinta, T; Kataoka, Y; Kishimoto, M; Okada, M; Rokutanda, R; Suda, M; Tomishima, Y | 1 |
| Abe, H; Fujimatsu, S; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Muta, T; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M | 1 |
| Azuma, N; Matsui, K; Okamura, H; Sano, H; Terada, M; Ueda, H | 1 |
| Hanawa, H; Kobayashi, D; Kuroda, T; Murakami, S; Nakano, M; Narita, I; Oda, M; Wada, Y | 1 |
4 other study(ies) available for mizoribine and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Effectiveness of multi-target therapy in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with early-stage interstitial lung disease.
Topics: Autoantibodies; Dermatomyositis; Drug Monitoring; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Male; Middle Aged; Prognosis; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Prednisolone; Renal Dialysis; Renal Insufficiency; Ribonucleosides; Treatment Outcome; Vasculitis | 2009 |
Mizoribine protects against bleomycin-induced lung injury.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Cell Proliferation; Disease Models, Animal; Female; Hydroxyproline; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Ribonucleosides; Time Factors | 2010 |
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug Therapy, Combination; Dyspnea; Etanercept; Female; Furosemide; Glucocorticoids; Hand; Heart Failure; Humans; Immunoglobulin G; Lung Diseases, Interstitial; Natriuretic Peptide, Brain; Propanolamines; Radiography; Receptors, Tumor Necrosis Factor; Rheumatoid Factor; Ribonucleosides; Scleroderma, Systemic; Spironolactone; Sulfasalazine; Tetrazoles; Treatment Outcome | 2011 |